| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1038c2500e1b19c73fa3a6d32703ffb3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6843
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 |
| filingDate |
2015-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d7b2c672724d379f7dca98997c5cf1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff5c64dd5ebc204e599c80caa474557d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4884f5a3b460024286652f4d4b002f0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f6a6088c0e04c5463f1c0974415555a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f5cf62d9138fde925ef335cb24602ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45eb156af62ca5db67d031d478396f67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cca947be899b13c2de25de47e0ef2f41 |
| publicationDate |
2015-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015108203-A1 |
| titleOfInvention |
Therapeutic pharmaceutical composition employing anti-slc6a6 antibody |
| abstract |
The present invention pertains to providing: a pharmaceutical composition for cancer therapy, in which a chemical therapeutic agent is conjugated to a novel monoclonal antibody that binds to SLC6A6 or the extracellular domain thereof; and a therapeutic method involving concomitant use of a chemical therapeutic agent and a monoclonal antibody or a therapeutic agent in which the chemical therapeutic agent is conjugated to the monoclonal antibody. The present invention provides a pharmaceutical composition containing an antibody conjugate in which a monoclonal antibody that has higher affinity than in the past and recognizes native SLC6A6 or polypeptides of the extracellular domain of SLC6A6 is conjugated to an anticancer agent or the like that has activity against hyperproliferative disorders such as cancer. |
| priorityDate |
2014-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |